Clinical trialNCT02641145RecruitingInterventional

Molecular Imaging of Primary Amyloid Cardiomyopathy

SponsorBrigham and Women's HospitalEnrollment171Amyloidosis, PrimaryCardiomyopathy

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Cardiac amyloidosis is a major cause of early treatment-related death and poor overall survival in individuals with systemic light chain amyloidosis. This project will develop a novel approach to visualize cardiac amyloid deposits using advanced imaging methods. The long-term goal of this work is to identify the mechanisms of cardiac dysfunction, in order to guide the development of novel life-saving treatments.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Rodney Falk, MD
Brigham and Women's Hospital (NIH Study)
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Ronglih Liao, PhD
Stanford School of Medicine (AHA Study)
Principal Investigator
clinicaltrials.gov ↗
Sharmila Dorbala, MD
Brigham and Women's Hospital (AHA and NIH Studies)
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Brigham and Womens' Hospital
Boston, Massachusetts, United States
Sharmila Dorbala, MBBS
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Apr 2016
Primary completion: 31 Dec 2027
Completion: 31 Dec 2028
Last update posted: 14 Nov 2025
Registered enrollment: 171
Registry id: NCT02641145

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.